Category Archives: Stem Cell Research

Lexington, MA (PRWEB) September 18, 2013 Melson is a gifted professional boxer who donates all of the money that he earns in the ring to spinal cord injury research. His advocacy efforts have been profiled on Emmy Award winning HBO series Real Sports, ESPN.com, Sports Illustrated and Yahoo. He is a founder of the organization Team Fight to Walk (http://www.teamfighttowalk.com), which through professional boxers and other athletes raises money for JustADollarPlease (http://www.justadollarplease.org), which supports efforts to bring clinical trials of adult stem cell treatments for spinal cord injury to the United States. In the United States alone, where a spinal cord injury occurs every 43 minutes, there are 300,000 people living with the tragic after-effects, said Melson. Of those, 40,000 are US Armed Forces Veterans. The exploding field of regenerative medicine holds great promise for the treatment of these injuries. My dearest friend in this world, Christan, who is the inspiration behind my passion for all things relating to spinal cord injury treatment, lives every day with the challenges resulting from a spinal cord injury. I have experienced firsthand, in her case, how adult stem cells can improve the quality of life. I live to help Christan and others like … Continue reading →

David Nutt And Howard Marks The Dangers Of Drugs The Dangers Of Drugs Drug Policy Reform November,2010 Drug laws amount to scientific censorship, says David Nutt David Nutt, and fellow professors Leslie K... By: ITZOUTTHERE … Continue reading →

Scientists have come a step closer to developing stem cell treatments for pancreatic diseases such as Type 1 diabetes. A 3D cell culture system was used to mass produce stem cells with the ability to become two kinds of pancreatic cell, including insulin-producing beta cells. The research, conducted on mice, involved cell signalling molecules known as Wnts that are inactive in the adult pancreas. "We have found a way to activate the Wnt pathway to produce an unlimited expansion of pancreatic stem cells isolated from mice," said study leader Dr Hans Clevers, from the Hubrecht Institute in Heidelberg, Germany. "By changing the growth conditions, we can select two different fates for the stem cells and generate large numbers of either hormone-producing beta cells or pancreatic duct cells." Stem cell research holds out great promise for diabetes sufferers who rely on daily insulin injections because they cannot produce insulin. Type 1 diabetes is an auto-immune disease that wipes out the beta cells in the pancreas. However, such research is still at a very early stage. The German scientists, whose findings appear in The EMBO Journal, now plan to extend their technique to human pancreatic cells. Read more here: Cell research hope … Continue reading →

Theres nothing new or even unexpected about the love-hate relationship between religion and science. The same Catholic Church that has often been a patron of the sciences think Gregor Mendel and the study of genetics, or Antoine Lavoisier and modern chemistry also found Galileo Galilei gravely suspect of heresy in 1633 for asserting Earth circled the sun. That history of friction between science and theology resurfaced in Wisconsin recently with the announcement that the 7,400 children who attend schools in the Madison Catholic Diocese will no longer be taking field trips to the Wisconsin Institutes for Discovery. Thats because the facility on the UW-Madison campus conducts research using human embryonic stem cells. The church has been pretty clear on how it feels about embryonic stem cells, so it shouldnt be all that surprising that it would draw a bright line about that particular discipline. Whether the rest of us like it or not, that position is consistent with the Catholic view that life begins at conception. For many in the church, it is a matter of faith. A separate question is whether the Madison Diocese should officially limit student access to a whole range of scientific disciplines most of which … Continue reading →

The Texas Medical Board on Friday approved controversial new rules on the use of adult stem cells, raising concerns that Texans could receive therapies that have not yet been proven to work and that could be unsafe. The new rules allow doctors to perform stem-cell procedures as long as they are done for research and receive approval from an institutional review board, which can be private and profit-making. The rules also require that patients sign informed consent forms. The approval process, which took months, was set off by Gov. Rick Perry, who reported relief from back pain after being injected with his own stem cells last summer before he began his presidential bid. Perry directed his staff to help push through the legislation on which the new rules are based. Researchers said the evidence of success of stem-cell injections is anecdotal, and they advocate waiting for clinical trial results before allowing doctors to charge patients for the procedures, which typically cost tens of thousands of dollars. I think there are some real problems with these rules, said Leigh Turner, a professor at the University of Minnesota's Center for Bioethics, who commented on the rules before the board. The protective mechanism … Continue reading →

Washington-AVatican-backed US company that researches an alternative to embryonic stem cells on Friday received a $1.2 million dollar government grant, despite independent studies that question whether their product exists. NeoStem, a New Jersey-headquartered company, is investigating very small embryonic-like (VSEL) cells found in adult bone marrow that they say may be able to regrow into different kinds of tissue. The research has stirred controversy due to NeoStems marketing partnership with theVatican and because three independent studies have been unable to confirm the cells are even there. The latest peer-reviewed grant, totaling $1,221,854, was provided by the US National Institutes of Health for research on an experimental drug that could regenerate bone tissue damaged by periodontitis, a serious gum disease. The company, along with other partner institutions, has already received $4.5 million in government research grants, including from the Department of Defense and the NIH. The NIH did not immediately respond to an AFP request for comment. We are very excited about our progress towards the IND (investigational new drug) submission for what we expect to be the first human clinical study for our VSEL Technology and for the support of the NIH, said a statement by NeoStem chief executive Robin … Continue reading →

stem cell research federal funding Federal Grants, State Grants, Foundation Grants More! http://bit.ly/freegrantmonies Are you aware that.... - 15, 000, 000 individuals obtain free aid in ad... By: Amy knowing … Continue reading →

WASHINGTON - A Vatican-backed US company that researches an alternative to embryonic stem cells on Friday received a $1.2 million dollar government grant, despite independent studies that question whether their product even exists. NeoStem, a New Jersey-headquartered company, is investigating very small embryonic-like (VSEL) cells found in adult bone marrow that they say may be able to regrow into different kinds of tissue. The research has stirred controversy due to NeoStem's marketing partnership with the Vatican and three independent studies that have been unable to confirm the cells are even there. The latest peer-reviewed grant, totaling $1,221,854, was provided by the US National Institutes of Health for research on an experimental drug that could regenerate bone tissue damaged by periodontitis, a serious gum disease. The company, along with other partner institutions, has already received $4.5 million in government research grants, including from the Department of Defense and the NIH. Link: Vatican-backed stem cell research gets $1.2-M US grant … Continue reading →

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix … Continue reading →

by Kerry Sheridan, Agence France-Presse Posted on 09/13/2013 11:48 PM |Updated 09/14/2013 12:08 AM PROMISING. Stem cells as seen on a computer screen at the University of Connecticut`s (UConn) Stem Cell Institute at the UConn Health Center on August 27, 2010 in Farmington, Connecticut, USA. Photo by Spencer Platt/Getty Images/AFP WASHINGTON DC, USA - A Vatican-backed US company that researches an alternative to embryonic stem cells on Friday received a $1.2-million-dollar government grant, despite independent studies that question whether their product exists. NeoStem, a New Jersey-headquartered company, is investigating very small embryonic-like (VSEL) cells found in adult bone marrow that they say may be able to regrow into different kinds of tissue. The research has stirred controversy due to NeoStem's marketing partnership with the Vatican and because three independent studies have been unable to confirm the cells are even there. The latest peer-reviewed grant, totaling $1,221,854, was provided by the US National Institutes of Health for research on an experimental drug that could regenerate bone tissue damaged by periodontitis, a serious gum disease. The company, along with other partner institutions, has already received $4.5 million in government research grants, including from the Department of Defense and the NIH. The NIH … Continue reading →